Skip to main content

Peer Review reports

From: Biological evaluation of novel gemcitabine analog in patient-derived xenograft models of pancreatic cancer

Original Submission
9 Jan 2023 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
27 Jan 2023 Reviewed Reviewer Report
5 Feb 2023 Reviewed Reviewer Report - Ralph Graeser
8 Feb 2023 Reviewed Reviewer Report - Nicole C. Mambelli-lisboa
22 Feb 2023 Reviewed Reviewer Report
14 Mar 2023 Author responded Author comments - Edward Agyare
Resubmission - Version 4
14 Mar 2023 Submitted Manuscript version 4
17 Mar 2023 Author responded Author comments - Edward Agyare
Resubmission - Version 5
17 Mar 2023 Submitted Manuscript version 5
28 Mar 2023 Reviewed Reviewer Report - Nicole C. Mambelli-lisboa
Resubmission - Version 6
Submitted Manuscript version 6
Publishing
7 May 2023 Editorially accepted
13 May 2023 Article published 10.1186/s12885-023-10928-w

You can find further information about peer review here.

Back to article page